Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fusobacterium nucleatum stimulates cell proliferation and promotes PD-L1 expression via IFIT1-related signal in colorectal cancer
Yaqi Gao, Tianhui Zou, Pingping Xu, et al.
Neoplasia (2022) Vol. 35, pp. 100850-100850
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications
Lin-Yong Zhao, Jia-Xin Mei, Gang Yu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 167
Fusobacterium nucleatum modulates the Wnt/β-catenin pathway in colorectal cancer development
Tanushree Mondal, Deepanjan Chattopadhyay, P. Mondal, et al.
International Journal of Biological Macromolecules (2025) Vol. 299, pp. 140196-140196
Closed Access | Times Cited: 2
Fusobacterium nucleatum carcinogenesis and drug delivery interventions
Zhenzhen Chen, Leaf Huang
Advanced Drug Delivery Reviews (2024) Vol. 209, pp. 115319-115319
Closed Access | Times Cited: 10
Emerging therapeutic frontiers in cancer: insights into posttranslational modifications of PD-1/PD-L1 and regulatory pathways
Rong Wang, Shiwei He, Jun Long, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 10
Fusobacterium nucleatum upregulates the immune inhibitory receptor PD-L1 in colorectal cancer cells via the activation of ALPK1
Coco Duizer, Moniek Salomons, Merel van Gogh, et al.
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 1
N6-methyladenosine RNA modification in PD-1/PD-L1: Novel implications for immunotherapy
Luo Ping, Shiqi Li, Xinghua Long
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 3, pp. 188873-188873
Closed Access | Times Cited: 16
Heart failure-induced microbial dysbiosis contributes to colonic tumour formation in mice
Sanne de Wit, Lotte Geerlings, Canxia Shi, et al.
Cardiovascular Research (2024) Vol. 120, Iss. 6, pp. 612-622
Open Access | Times Cited: 6
Fusobacterium species are distinctly associated with patients with Lynch syndrome colorectal cancer
Felix Salim, Sayaka Mizutani, Satoshi Shiba, et al.
iScience (2024) Vol. 27, Iss. 7, pp. 110181-110181
Open Access | Times Cited: 6
m6A modification on the fate of colorectal cancer: functions and mechanisms of cell proliferation and tumorigenesis
Xiaohan Jiang, Ziyao Jin, Yuzhong Yang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 13
Gut microbiome: decision-makers in the microenvironment of colorectal cancer
Jingrun Han, Biao Zhang, Yongnian Zhang, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 12
Potential role of the intratumoral microbiota in colorectal cancer immunotherapy
Shiying Fan, Wenjie Zhang, Lujia Zhou, et al.
International Immunopharmacology (2024) Vol. 137, pp. 112537-112537
Closed Access | Times Cited: 4
Role of the oral-gut microbiota axis in pancreatic cancer: a new perspective on tumor pathophysiology, diagnosis, and treatment
Xuanchi Guo, Yuhan Shao
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access
RNA modifications in the tumor microenvironment: insights into the cancer-immunity cycle and beyond
Yuan Ding, Cuicui Liu, Ke‐Da Yu
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access
How the interplay among the tumor microenvironment and the gut microbiota influences the stemness of colorectal cancer cells
María Belén Novoa Díaz, Pedro Carriere, Claudia Gentili
World Journal of Stem Cells (2023) Vol. 15, Iss. 5, pp. 281-301
Open Access | Times Cited: 9
IFIT3 accelerates the progression of head and neck squamous cell carcinoma by targeting PD-L1 to activate PI3K/AKT signaling pathway
Peng Liu, Xin Kong, Shijiang Yi, et al.
World Journal of Surgical Oncology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
The therapeutic impact of programmed death – 1 in the treatment of colorectal cancer
Pooria Salehi Sangani, Soroush Yazdani, Ghazaleh Khalili‐Tanha, et al.
Pathology - Research and Practice (2024) Vol. 259, pp. 155345-155345
Closed Access | Times Cited: 3
Role of N6‐methyladenosine RNA modification in cancer
Yi Qu, Nannan Gao, Shengwei Zhang, et al.
MedComm (2024) Vol. 5, Iss. 9
Open Access | Times Cited: 3
Therapeutic Target Identification and Inhibitor Screening against Riboflavin Synthase of Colorectal Cancer Associated Fusobacterium nucleatum
Norah A. Alturki, Mutaib M. Mashraqi, Khurshid Jalal, et al.
Cancers (2022) Vol. 14, Iss. 24, pp. 6260-6260
Open Access | Times Cited: 12
N6-methyladenosine-dependent signaling in colorectal cancer: Functions and clinical potential
Shaojun Liu, Min Liu, Yuxuan Li, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 198, pp. 104360-104360
Open Access | Times Cited: 2
RNA modifications in cancer immune therapy: regulators of immune cells and immune checkpoints
Xiangyu Qin, Huali Liu, Qixuan Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Progress of tumor-resident intracellular bacteria for cancer therapy
Peng Bao, Xian‐Zheng Zhang
Advanced Drug Delivery Reviews (2024) Vol. 214, pp. 115458-115458
Closed Access | Times Cited: 2
IFIT1 + neutrophil is a causative factor of immunosuppressive features of poorly cohesive carcinoma (PCC)
Yuan-jie Liu, Jie-pin Li, Mei Han, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Intratumoral Microbiota: Insights from Anatomical, Molecular, and Clinical Perspectives
Claudia Lombardo, Rosario Fazio, Marta Sinagra, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 11, pp. 1083-1083
Open Access | Times Cited: 2
N6-methyladenosine modification: an important player in the tumor immune microenvironment
Jiaxiang Hu, Chen Xue, Qingqing Wang
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115171-115171
Open Access | Times Cited: 5
Inverse relationship between Fusobacterium nucleatum amount and tumor CD274 (PD‐L1) expression in colorectal carcinoma
Tomotaka Ugai, Takashi Shimizu, Hidetaka Kawamura, et al.
Clinical & Translational Immunology (2023) Vol. 12, Iss. 8
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top